ANRO (Alto Neuroscience) Other Long Term Assets : $0.50 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Other Long Term Assets?

Alto Neuroscience's other long-term assets for the quarter that ended in Dec. 2024 was $0.50 Mil.

Alto Neuroscience's quarterly other long-term assets declined from Jun. 2024 ($0.50 Mil) to Sep. 2024 ($0.50 Mil) but then increased from Sep. 2024 ($0.50 Mil) to Dec. 2024 ($0.50 Mil).

Alto Neuroscience's annual other long-term assets declined from Dec. 2022 ($0.46 Mil) to Dec. 2023 ($0.13 Mil) but then increased from Dec. 2023 ($0.13 Mil) to Dec. 2024 ($0.50 Mil).

Alto Neuroscience Other Long Term Assets Historical Data

The historical data trend for Alto Neuroscience's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Other Long Term Assets Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

0.05

0.46

0.13

0.50

Alto Neuroscience Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial					0.13	0.06	0.50	0.50	0.50

Alto Neuroscience Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Alto Neuroscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 Castro Street, Suite 450, Mountain View, CA, USA, 94041

Website

https://www.altoneuroscience.com

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.